
    
      The primary objective of this study was to evaluate the feasibility of implementing Genomic
      Grade Index (GGI) in community hospitals in Belgium for breast cancer patients with node
      negative and 1-3 node positive early breast cancer. GGI would be considered a feasible
      genomic test if results were obtained in > 70% of evaluated patients.
    
  